placebo Diskus®

DEVICE2 trials

Sponsors

Boehringer Ingelheim, University Hospital, Bordeaux

Conditions

AsthmaPulmonary Disease, Chronic Obstructive

Phase 2

Salmeterol Inhalation Powder Administered as the Xinafoate Salt From Hard Polyethylene Capsules Via the HandiHaler® 2, and Serevent® Diskus® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT02238106

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2005-09-30Updated: 2014-09-12

Unknown Phase

Description of the Ability to Learn How to Handle Inhaler Devices in Asthma

WithdrawnNCT03175926

University Hospital, BordeauxAsthma

Start: 2017-12-01End: 2018-09-01Updated: 2019-02-04